TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2008

Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197.

Lori J Goldstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.